The Global Market for Contraceptives is Forecast to Exceed US$28 Billion by 2022

Growing Focus on Healthy Sexuality Drives Global Demand for Reliable Contraceptives, According to a New Report by Global Industry Analysts, Inc.

GIA launches comprehensive analysis of industry segments, trends, growth drivers, market share, size and demand forecasts on the global Contraceptives market. The global market for Contraceptives is forecast to exceed US$28 billion by 2022, driven by the growing public awareness over sexual well-being and rising focus of public health systems on birth control and prevention of sexually transmitted diseases.   

Intervention of the ovulation and/or fertilization processes and thereby preventing pregnancy through the means of drugs or devices is called contraception. Birth control over the years revolutionized women’s health, planned parenting, and society, while at the same time improving the material, living, academic, and social status of women and families across the world. The rate of usage of contraceptives rose from 36% in 1970 to 64% in 2015, as per United Nations data. In the US alone, there was over 85% decline in teen pregnancies between 2002 and 2016 due to increased usage of contraceptives. Key factors that are driving steady growth in demand for contraceptives include increasing awareness of reproductive health, changing lifestyles and the desire to avoid unwanted pregnancies, as well as the need to avoid risk of sexually transmitted diseases (STDs) such as HIV/AIDS. Efforts by market participants, NGOs and governments worldwide to promote the use of contraceptives are providing further impetus to market adoption with temporary methods of contraception, especially condoms and oral contraceptive pills, enjoying the highest popularity.

Healthy growth is projected for the market in the coming years driven by the pressing need for family planning against the backdrop of rapid growth in the global population, which is also a growth driving factor as increase in population means more number of sexually active people that make use of contraceptives. Increased awareness of sexually transmitted infections (STIs); favorable government efforts and initiatives in order to cut unwanted healthcare expenditure associated with abortions; development of emergency contraceptives that witness higher usage among teenagers; rising popularity of female condoms, and steady launch of novel, advanced products such as custom-fit condoms represent other important growth drivers benefiting market expansion in the near term. The growing trend of planned parenthood among young couples is also expected to fuel sales growth in the market. On the other hand, side effects associated with certain contraceptives such as risk of infection, infertility and depression impede market growth. The market is also challenged by socio-cultural concerns regarding contraceptive usage, particularly in the Asian and African countries.

As stated by the new market research report on Contraceptives, the United States represents the largest market worldwide, driven by high awareness levels and increasing adoption of modern contraception methods. Asia-Pacific represents the fastest growing market with a CAGR of 6.2% over the analysis period. High population base; increasing efforts of governmental bodies regarding birth control;  presence of China and India that represent two countries with the largest sexually active population of 15-64 years age group in the world; and unpenetrated and underpenetrated nature of the market offer huge market growth opportunities in the region.

Key players covered in the report include Agile Therapeutics, Inc., Allergan plc, Ansell Limited, Bayer AG, Church & Dwight Co., Inc., CooperSurgical Inc., Fuji Latex Co. Ltd., Janssen Pharmaceuticals, Inc., Karex Berhad, Mankind Pharma Ltd., Merck Sharp & Dohme Corp., Okamoto Industries, Inc., Pfizer, Inc., Piramal Enterprises Ltd., Reckitt Benckiser Group Plc., Sagami Rubber Industries Co., Ltd., Teva Pharmaceutical Industries Ltd., and Thai Nippon Rubber Industry Co., Ltd., among others.

The research report titled “Contraceptives: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, issues, drivers, mergers, acquisitions and other strategic industry activities of major companies. The report provides market estimates and projections for all major geographic markets, including the United States, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia and Rest of Europe), Asia-Pacific (China, India, and Rest of Asia-Pacific), Latin America (Brazil and Rest of Latin America), and Rest of World markets. Contraception methods analyzed in the report include Hormonal Contraceptives (Oral Contraceptives, and Other Hormonal Contraceptives), and Condoms.

Global Industry Analysts, Inc. 6150 Hellyer Ave., San Jose CA 95138, USA, All Rights Reserved.